lactic acid has been researched along with ursodoxicoltaurine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arranz-Romera, A; Bravo-Osuna, I; Cuenca, N; Esteban-Pérez, S; Fernández-Sánchez, L; Herrero-Vanrell, R; Lax, P; Maneu, V; Pinilla, I; Puebla-González, MDM | 1 |
| Arranz-Romera, A; Bravo-Osuna, I; Esteban-Pérez, S; Herrero-Vanrell, R; Molina-Martínez, IT | 1 |
2 other study(ies) available for lactic acid and ursodoxicoltaurine
| Article | Year |
|---|---|
Controlled delivery of tauroursodeoxycholic acid from biodegradable microspheres slows retinal degeneration and vision loss in P23H rats.
Topics: Animals; Blindness; Delayed-Action Preparations; Disease Models, Animal; Electroretinography; Lactic Acid; Microspheres; Neuroprotective Agents; Particle Size; Photoreceptor Cells, Vertebrate; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Sprague-Dawley; Retina; Retinal Degeneration; Retinitis Pigmentosa; Taurochenodeoxycholic Acid | 2017 |
Co-delivery of glial cell-derived neurotrophic factor (GDNF) and tauroursodeoxycholic acid (TUDCA) from PLGA microspheres: potential combination therapy for retinal diseases.
Topics: Emulsions; Glial Cell Line-Derived Neurotrophic Factor; Humans; Lactic Acid; Microspheres; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Retinal Diseases; Taurochenodeoxycholic Acid | 2021 |